DECHRA PHARMACEUTICA

DPH

Delayed - 05/26 11:35:18 am
3552GBX	+1.78%

Turn to zoom

Prev.	3552.0000
Open	3502.0000
High	3552.0000
Low	3456.0000
Volume	152 582

05/17	Dechra Pharmaceuticals PLC Announces Executive Changes
04/26	Jefferies Reduces Dechra Pharmaceuticals PT, Keeps Hold Rating
04/08	FTSE 100 Closes Higher Led by Mining, Energy Stocks
03/03	DECHRA PHARMACEUTICALS PLC : Ex-dividend day for interim dividend

	Short Term	Mid-Term	Long Term
Trend	Bearish	Bearish	Bearish
Resistance	3 638	4 272	4 272
Spread/Res.	-4,9%	-19%	-19%
Spread/Supp.	10,0%	10,0%	6,4%
Support	3 148	3 148	3 254

Sales 2022	664 M 834 M 834 M
Net income 2022	77,0 M 96,7 M 96,7 M
Net Debt 2022	162 M 204 M 204 M
P/E ratio 2022	51,3x
Yield 2022	1,26%

Capitalization	3 783 M 4 750 M 4 750 M
EV / Sales 2022	5,94x
EV / Sales 2023	5,39x
Nbr of Employees	-
Free-Float	98,6%

Dechra Pharmaceuticals PLC is engaged in veterinary pharmaceuticals and related products business. The Company is engaged in development, manufacture and marketing of products for veterinarians. Its segments include European Pharmaceuticals, North American (NA) Pharmaceuticals and Pharmaceuticals...

>> Read more

Sector :

Veterinary Drugs

Calendar :

2022-09-05 Earnings Release

Trading Rating :

Investor Rating :

Sell Buy
Mean consensus	OUTPERFORM
Number of Analysts	10
Last Close Price	3 490,00 GBX
Average target price	4 842,70 GBX
Spread / Average Target	38,8%